Back to Search Start Over

Incomplete Functional Revascularization Is Associated With Adverse Clinical Outcomes After Transcatheter Aortic Valve Implantation.

Authors :
Scarsini R
Venturi G
Pighi M
Lunardi M
Kotronias R
Del Sole PA
Rubino F
Tavella D
Pesarini G
Banning A
Ribichini F
Source :
Cardiovascular revascularization medicine : including molecular interventions [Cardiovasc Revasc Med] 2022 Sep; Vol. 42, pp. 47-52. Date of Electronic Publication: 2022 Feb 28.
Publication Year :
2022

Abstract

Background and Purpose: Whether incomplete functional revascularization has an impact on the clinical outcome of patients treated with transcatheter aortic valve implantation (TAVI) is still unknown. We aim to assess the prognostic value of residual functional SYNTAX score (rFSS) in a cohort of patients undergoing TAVI.<br />Methods and Results: One-hundred-twenty-four patients (229 lesions) with severe aortic stenosis and coronary artery disease (CAD) underwent fractional flow reserve (FFR)-guided revascularization. The primary endpoint of the study was the composite of cardiac death, myocardial infarction, and revascularization at the last available follow-up after TAVI. Median SYNTAX score (SS) and Functional SYNTAX score (FSS) at baseline were 7 (range 5-12) and 0 (range 0-7) respectively. After revascularization or deferral according to FFR, residual SS (rSS) and rFSS were 5 (range 0-8) and 0 (range 0-0) respectively. Angiographic incomplete revascularization (rSS > 0) was not associated with the primary endpoint (HR 1.2; 95% CI 0.4-3.9; p = 0.69), whereas functional incomplete revascularization (rFSS>0) was associated with worse event-free survival at follow up after adjusting for clinical confounders (HR 3.7; 95% CI 1.0-13.7; p = 0.04).<br />Conclusion: Incomplete functional revascularization is associated with adverse clinical outcomes after TAVI. Residual functional SYNTAX score may be regarded as a treatment goal for patients with CAD undergoing TAVI. Further studies are warranted to confirm our hypothesis.<br />Competing Interests: Declaration of competing interest None. All authors participated in the research and preparation of the manuscript.<br /> (Copyright © 2022 Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1878-0938
Volume :
42
Database :
MEDLINE
Journal :
Cardiovascular revascularization medicine : including molecular interventions
Publication Type :
Academic Journal
Accession number :
35272945
Full Text :
https://doi.org/10.1016/j.carrev.2022.02.024